Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Healthcare Prescriptive Analytics Market

Healthcare Prescriptive Analytics Market Analysis

  • Report ID: GMI8061
  • Published Date: Feb 2024
  • Report Format: PDF

Healthcare Prescriptive Analytics Market Analysis

Based on the component, the market is classified into software and services. The software segment is anticipated to maintain its dominance, generating revenue of USD 2.3 billion in 2023, and is expected to continue similar trend throughout the forecast period.
 

  • The software segment involves sophisticated algorithms, models, and analytical tools essential for processing and interpreting healthcare data. As healthcare organizations are increasingly prioritizing data-driven decision-making, the demand for prescriptive analytics software is expected to surge.
     
  • Also, these software solutions empower professionals to derive actionable insights, enhance clinical decision support, and improve overall operational efficiency, thereby solidifying the software segment's prominence in the dynamic landscape of healthcare prescriptive analytics.
     
Healthcare Prescriptive Analytics Market, By Deployment Model (2023)

Based on deployment model, the healthcare prescriptive analytics market is classified into on-premise and cloud-based. The cloud-based model is expected to hold the highest market share of 57.8% in 2023.
 

  • Cloud-based solutions gained prominence due to their scalability, accessibility, and cost-effectiveness. This model offered healthcare organizations for flexibility to manage and analyze vast datasets efficiently.
     
  • Moreover, the cloud's collaborative and real-time capabilities facilitated seamless integration and information sharing among healthcare stakeholders. The need for agility in responding to dynamic healthcare challenges further fueled the adoption of cloud-based prescriptive analytics, making it the preferred deployment choice, thereby fostering the market growth.
     

Based on application, the healthcare prescriptive analytics market is classified into clinical management, financial management, operation management, and other applications. The clinical management is expected hold the highest throughout the forecast period.
 

  • The clinical management prominence can be attributed due to the growing focus on optimizing clinical processes, enhancing patient care, and improving the healthcare delivery.
     
  • Prescriptive analytics provide insights aiding in treatment decisions, resource allocation, and workflow optimization within the clinical settings. The emphasis on achieving better patient outcomes and operational efficiency intends to drive the widespread adoption of prescriptive analytics in clinical management, marking its dominance in the broader healthcare analytics landscape.
     

Based on end-use, the healthcare prescriptive analytics market is classified into hospitals, clinics, and other end-users. The hospitals are anticipated to secure the largest market share in 2023 and is anticipated to show similar trend during the analysis period with a CAGR of 12.6%.
 

  • The dominance of the hospital end-user in the market can be attributed to the critical need for efficient patient care and resource management within healthcare facilities.
     
  • The complex and data-intensive nature of hospital operations, including patient records and treatment protocols, makes prescriptive analytics invaluable. This segment's dominance signifies a growing recognition among healthcare providers of the transformative impact prescriptive analytics can have on delivering targeted, data-driven interventions for better patient care and operational excellence.
     
North America Healthcare Prescriptive Analytics Market, 2020- 2032 (USD Billion)

In 2023, North America secured a substantial market share in the global healthcare prescriptive analytics market and is expected to dominate throughout the forecast period.
 

  • Advanced healthcare infrastructure, widespread adoption of digital technologies, and a strong commitment to data-driven decision-making are few of the drivers that influence the market.
     
  • Also, the significant investments in healthcare IT, and the presence of major technology players contribute to its leadership. The proactive approach of healthcare providers towards adopting innovative solutions solidifies its position in harnessing prescriptive analytics for improved patient care, operational efficiency, and strategic decision-making in the healthcare sector.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global healthcare prescriptive analytics industry was valued at USD 3.6 billion in 2023 and is expected to reach USD 12.9 billion by 2032 as it provides specific guidance on actions to improve patient outcomes, operational efficiency, and overall healthcare processes.

The software segment generated revenue of USD 2.3 billion in 2023 and will grow significantly through 2032 as healthcare organizations are increasingly prioritizing data-driven decision-making.

In 2023, North America secured a substantial share in the healthcare prescriptive analytics market and is expected to grow through 2032, owing to the presence of advanced healthcare infrastructure, widespread adoption of digital technologies, and a strong commitment to data-driven decision-making.

AIMMS, Alteryx, Deerwalk Inc., FICO, Frontline Systems, Inc., GUROBI OPTIMIZATION, LLC., Health Catalyst, IBM Corporation, Optum, Inc., Oracle Corporation, River Logic, Inc., and SAS Institute Inc.

Healthcare Prescriptive Analytics Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 251
  • Countries covered: 19
  • Pages: 170
 Download Free Sample